Takaaki Miyazaki

Biomarker Expert Bayer

Seminars

Tuesday 19th May 2026
Panel Discussion: Bridging Regional & Global Priorities to Inform the Selection of CDx Partners & Workflows
9:40 am
  • Exploring how Japan-specific regulatory, clinical, and reimbursement considerations can be aligned with global CDx development strategies
  • Sharing practical approaches for selecting CDx partners and designing workflows that balance regional requirements with global launch objectives
Takaaki Miyazaki - Biomarker Expert, Bayer Yakuhin